<DOC>
	<DOCNO>NCT02310789</DOCNO>
	<brief_summary>Clinical study lumacaftor + ivacaftor ( combo therapy ) produce good FEV1 ( forced expiratory volume 1 second ) improvement ivacaftor alone , without improvement sweat chloride result . To help understand sweat chloride unresponsive , investigator use newly develop sweat secretion test provide accurate , vivo readout CFTR ( cystic fibrosis transmembrane conductance regulator ) function sweat gland secretory coil . The investigator devise protocol determine short course ivacaftor ( 3.5 day ) produce significant increase WT ( Wild-Type , i.e . normal ) CFTR open probability measure CFTR-dependent sweating ( C-sweat ) subject WT CFTR .</brief_summary>
	<brief_title>( Study : Vertex IIS ) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil ?</brief_title>
	<detailed_description>Cystic fibrosis ( CF ) genetic disease cause malfunction protein call CFTR . CF affect various organ include sweat gland lung . An FDA approve drug call ivacaftor help people CF , laboratory test show produce improvement combine investigational drug call lumacaftor . However , result clinical test two drug use together give mixed result : lung function improve sweat gland function improve . This study measure CFTR-dependent sweat rate test hypothesis CFTR normal sweat gland might function peak efficiency , ca n't improve ivacaftor , thus account apparent discrepancy lung function sweat gland result . CFTR-dependent sweat rate important understanding CF accurate measure CFTR function .</detailed_description>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Healthy adult without Cystic Fibrosis ( CF ) mutation Carriers know CF mutation 1 . Documented liver disease 2 . Participants take : medicine strong CYP3A ( Cytochrome P450 , family 3 , subfamily A ) inducer , : antibiotic rifampin rifabutin ; seizure medication ( phenobarbital , carbamazepine , phenytoin ) ; herbal supplement St. John 's Wort , substantially decrease exposure ivacaftor may diminish effectiveness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>